Biogen, Eli Lilly drugs to expand imaging market for companies in diagnostics sector.
Tag: life science
Biogen to Cut Roughly 11% of Workforce to Focus on Big-Return Drugs
The biotech company cited the launch of Alzheimer’s drug Lekembi as part of its new focus…
Dove Maker Unilever Still Raising Prices as Volumes Slip
The consumer-goods giant — a scourge for the global economy and consumer sentiment — raised prices…
Big Pharma Bets Big on China
China remains attractive to global pharmaceutical companies, even as many multinationals are turning their attention elsewhere.
WSJ News Exclusive | At Startup That Says Its AI Writes Medical Records, Humans Do a Lot of the Work
DeepScribe relies on a team of people to review technology-generated reports, listen in on medical conversations,…
How U.S. Drug Companies Could Tip Europe Into Recession
Fluctuations in Ireland’s pharmaceutical industry, often caused by tax moves by US-based companies, have a strong…
Dow Edges Higher, Its 10th Gain in a Row
Healthcare and financial stocks moved into positive territory this week for the year.
Tornado Damages Key Pfizer Drugmaking Plant
The plant in Rocky Mount, NC, produces a quarter of the sterile injectable drugs used by…
Surge in Heart Procedures Helps Drive Johnson & Johnson Revenue
The pharmaceutical company’s net income rose 6.9% to $5.14 billion, or $1.96 per share.
Johnson & Johnson Rips Off the Kenvue Band-Aid
The surprisingly quick delivery and extended evaluation hit J&J’s consumer health arm hard.